| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.81▲ | 0.81▲ | 0.81▲ | 0.79▲ | 1.08▼ |
| MA10 | 0.84▼ | 0.88▼ | 0.90▼ | 0.90▼ | 1.44▼ |
| MA20 | 0.97▼ | 1.01▼ | 1.03▼ | 1.12▼ | N/A |
| MA50 | 1.20▼ | 1.23▼ | 1.28▼ | 1.58▼ | N/A |
| MA100 | 1.44▼ | 1.49▼ | 1.55▼ | N/A | N/A |
| MA200 | 1.64▼ | 1.73▼ | 1.87▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.014▼ | -0.017▼ | -0.001▼ | N/A |
| RSI | 30.027▼ | 29.863▼ | 27.556▼ | 25.925▼ | N/A |
| STOCH | 13.508▼ | 10.384▼ | 8.040▼ | 11.087▼ | N/A |
| WILL %R | -87.417▼ | -88.623▼ | -88.623▼ | -84.211▼ | -98.957▼ |
| CCI | -55.187 | -69.283 | -70.824 | -68.420 | -107.999▼ |
|
Monday, November 17, 2025 05:55 AM
Propanc continues to advance its lead candidate, PRP, toward a world-first Phase 1b clinical study in 30–40 patients with advanced solid tumors at the Peter Mac Cancer Center in Melbourne. GMP ...
|
|
Monday, November 17, 2025 05:50 AM
Our first quarter delivered meaningful progress across clinical, financial, and strategic initiatives,” said James Nathanielsz, CEO of Propanc.
|
|
Tuesday, November 11, 2025 04:00 AM
Biotech secures $100M from Hexstone Capital for crypto treasury but shares drop 10.5%. Down 46.7% in past month.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/11/25 | 0.7999 | 0.82 | 0.7999 | 0.82 | 66,177 |
| 17/11/25 | 0.78 | 0.78 | 0.741 | 0.7558 | 52,261 |
| 14/11/25 | 0.77 | 0.7899 | 0.73 | 0.7773 | 106,696 |
| 13/11/25 | 0.8373 | 0.8403 | 0.77 | 0.782 | 72,671 |
| 12/11/25 | 0.82 | 0.87 | 0.8058 | 0.8373 | 40,084 |
| 11/11/25 | 0.90 | 0.90 | 0.7671 | 0.8406 | 224,596 |
| 10/11/25 | 0.977 | 1.00 | 0.8418 | 0.902 | 2,457,700 |
| 07/11/25 | 1.0905 | 1.109 | 0.96 | 1.03 | 92,512 |
| 06/11/25 | 1.17 | 1.17 | 1.0968 | 1.113 | 22,893 |
| 05/11/25 | 1.03 | 1.20 | 1.03 | 1.18 | 119,428 |
|
|
||||
|
|
||||
|
|